Retatrutide works through three metabolic pathways simultaneously:
- GLP-1 receptor activation
→ reduces appetite and slows gastric emptying - GIP receptor activation
→ supports insulin response and metabolic balance - Glucagon receptor activation
→ increases energy expenditure and fat utilization
Overall Effect:
→ Appetite control + fat utilization + metabolic activation
→ Full-spectrum metabolic regulation
Triple-Receptor Activation Studies
Research indicates that Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, resulting in broader metabolic effects compared to single-pathway compounds.
Weight Management Research
Preclinical and clinical models suggest significant reductions in body weight through appetite regulation and increased energy expenditure.
Energy Expenditure Studies
Unlike traditional GLP-1 compounds focused mainly on appetite suppression, Retatrutide has been studied for enhancing calorie utilization and metabolic activity.
Metabolic Health Models
Research suggests improvements in glucose regulation, insulin sensitivity, and lipid metabolism.
Intended Use:
Retatrutide is intended for research purposes only. Reconstitution with bacteriostatic water (BAC water) is required before use.
Storage:
Store lyophilized powder in a cool, dry place away from direct sunlight. After reconstitution, keep refrigerated at 2–8°C.
Solubility:
Reconstitute gently with BAC water. Do not shake.
Vial Size:
Lyophilized multi-dose vial depending on specification.
Shelf Life:
Lyophilized: up to 24 months
Reconstituted: recommended use within 4–6 weeks
Handling:
Use sterile techniques to maintain product stability and integrity.
